![Jason Glashow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Glashow worked as the Head of Corporate Communications at Biogen, Inc., Senior Vice President & Senior Partner at Fleishman-Hillard, Inc., Senior Vice President of Corporate Affairs at Frequency Therapeutics, Inc., and Head of Communications at Moderna, Inc. He received his undergraduate degree from Washington University in St. Louis and his graduate degree from Boston University.
| Companies | Position | End |
|---|---|---|
Fleishman-Hillard, Inc.
 Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
| KORRO BIO, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Public Communications Contact | - |
| MODERNA, INC. | Public Communications Contact | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fleishman-Hillard, Inc.
Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
